Sudhakar Voruganti
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Heat shock proteins research, Protein Structure and Dynamics, Computational Drug Discovery Methods, Monoclonal and Polyclonal Antibodies Research, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Elucidation of the Hsp90 C-Terminal Inhibitor Binding Site(2011)108 cited
- → The Anticancer Drug AUY922 Generates a Proteomics Fingerprint That Is Highly Conserved among Structurally Diverse Hsp90 Inhibitors(2013)25 cited
- → Proteomic Profiling of Hsp90 Inhibitors(2017)11 cited
- → A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology(2020)5 cited
- → A comprehensive strategy for the identification of biologics by liquid-chromatography–mass spectrometry for release testing in a regulated environment(2023)4 cited
- The proteomics fingerprints of AUY922 and 17-DMAG indicate common mechanisms of action for Hsp90 inhibitors(2013)